Authors:
ROMANOVA LY
ALEXANDROV IA
NORDAN RP
BLAGOSKLONNY MV
MUSHINSKI JF
Citation: Ly. Romanova et al., CROSS-TALK BETWEEN PROTEIN-KINASE-C-ALPHA (PKC-ALPHA) AND PKC-DELTA (PKC-DELTA) - PKC-ALPHA ELEVATES THE PKC-DELTA PROTEIN LEVEL, ALTERING ITS MESSENGER-RNA TRANSCRIPTION AND DEGRADATION, Biochemistry, 37(16), 1998, pp. 5558-5565
Authors:
ROHLFF C
BLAGOSKLONNY MV
KYLE E
KESARI A
KIM IY
ZELNER DJ
HAKIM F
TREPEL J
BERGAN RC
Citation: C. Rohlff et al., PROSTATE-CANCER CELL-GROWTH INHIBITION BY TAMOXIFEN IS ASSOCIATED WITH INHIBITION OF PROTEIN-KINASE-C AND INDUCTION OF P21(WAF1 CIP1)/, The Prostate, 37(1), 1998, pp. 51-59
Authors:
BLAGOSKLONNY MV
GIANNAKAKOU P
WOJTOWICZ M
ROMANOVA LY
AIN KB
BATES SE
FOJO T
Citation: Mv. Blagosklonny et al., EFFECTS OF P53-EXPRESSING ADENOVIRUS ON THE CHEMOSENSITIVITY AND DIFFERENTIATION OF ANAPLASTIC THYROID-CANCER CELLS, The Journal of clinical endocrinology and metabolism, 83(7), 1998, pp. 2516-2522
Authors:
BLAGOSKLONNY MV
AN WG
ROMANOVA LY
TREPEL J
FOJO T
NECKERS L
Citation: Mv. Blagosklonny et al., P53 INHIBITS HYPOXIA-INDUCIBLE FACTOR-STIMULATED TRANSCRIPTION, The Journal of biological chemistry, 273(20), 1998, pp. 11995-11998
Citation: Mv. Blagosklonny, THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY MEDIATES GROWTH ARREST OR E1A-DEPENDENT APOPTOSIS IN SKBR3 HUMAN BREAST-CANCER CELLS, International journal of cancer, 78(4), 1998, pp. 511-517
Citation: Mv. Blagosklonny et Ws. Eldeiry, ACUTE OVEREXPRESSION OF WT P53 FACILITATES ANTICANCER DRUG-INDUCED DEATH OF CANCER AND NORMAL-CELLS, International journal of cancer, 75(6), 1998, pp. 933-940
Citation: Wg. An et al., INHIBITORS OF TRANSCRIPTION, PROTEASOME INHIBITORS, AND DNA-DAMAGING DRUGS DIFFERENTIALLY AFFECT FEEDBACK OF P53 DEGRADATION, Experimental cell research, 244(1), 1998, pp. 54-60
Authors:
PORUCHYNSKY MS
WANG EE
RUDIN CM
BLAGOSKLONNY MV
FOJO T
Citation: Ms. Poruchynsky et al., BCL-X(L) IS PHOSPHORYLATED IN MALIGNANT-CELLS FOLLOWING MICROTUBULE DISRUPTION, Cancer research, 58(15), 1998, pp. 3331-3338
Authors:
BLAGOSKLONNY MV
IGLESIAS A
ZHAN ZR
FOJO T
Citation: Mv. Blagosklonny et al., LIKE P53, THE PROLIFERATION-ASSOCIATED PROTEIN P120 ACCUMULATES IN HUMAN CANCER-CELLS FOLLOWING EXPOSURE TO ANTICANCER DRUGS, Biochemical and biophysical research communications, 244(2), 1998, pp. 368-373
Authors:
BLAGOSKLONNY MV
WU GS
SOMASUNDARAM K
ELDEIRY WS
Citation: Mv. Blagosklonny et al., WILD-TYPE P53 IS NOT SUFFICIENT FOR SERUM STARVATION-INDUCED APOPTOSIS IN CANCER-CELLS BUT ACCELERATES APOPTOSIS IN SENSITIVE CELLS, International journal of oncology, 11(6), 1997, pp. 1165-1170
Authors:
WHITESELL L
SUTPHIN P
AN WG
SCHULTE T
BLAGOSKLONNY MV
NECKERS L
Citation: L. Whitesell et al., GELDANAMYCIN-STIMULATED DESTABILIZATION OF MUTATED P53 IS MEDIATED BYTHE PROTEASOME IN-VIVO, Oncogene, 14(23), 1997, pp. 2809-2816
Authors:
AN WG
SCHNUR RC
NECKERS L
BLAGOSKLONNY MV
Citation: Wg. An et al., DEPLETION OF P185(ERBB2), RAF-1 AND MUTANT P53 PROTEINS BY GELDANAMYCIN DERIVATIVES CORRELATES WITH ANTIPROLIFERATIVE ACTIVITY, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 60-64
Citation: Mv. Blagosklonny et al., DEFECTS IN P21(WAF1 CIP1), RB, AND C-MYC SIGNALING IN PHORBOL ESTER-RESISTANCE CANCER-CELLS/, Cancer research, 57(2), 1997, pp. 320-325
Authors:
BLAGOSKLONNY MV
GIANNAKAKOU P
ELDEIRY WS
KINGSTON DGI
HIGGS PI
NECKERS L
FOJO T
Citation: Mv. Blagosklonny et al., RAF-1 BCL-2 PHOSPHORYLATION - A STEP FROM MICROTUBULE DAMAGE TO CELL-DEATH/, Cancer research, 57(1), 1997, pp. 130-135
Citation: Ns. Prabhu et al., SUPPRESSION OF CANCER CELL-GROWTH BY ADENOVIRUS EXPRESSING P21(WAF1 CIP1) DEFICIENT IN PCNA INTERACTION/, Clinical cancer research, 2(7), 1996, pp. 1221-1229
Authors:
SCHULTE TW
BLAGOSKLONNY MV
ROMANOVA L
MUSHINSKI JF
MONIA BP
JOHNSTON JF
NGUYEN P
TREPEL J
NECKERS LM
Citation: Tw. Schulte et al., DESTABILIZATION OF RAF-1 BY GELDANAMYCIN LEADS TO DISRUPTION OF THE RAF-1-MEK-MITOGEN-ACTIVATED PROTEIN-KINASE SIGNALING PATHWAY, Molecular and cellular biology, 16(10), 1996, pp. 5839-5845
Authors:
BLAGOSKLONNY MV
ALVAREZ M
FOJO A
NECKERS LM
Citation: Mv. Blagosklonny et al., BCL-2 PROTEIN DOWN-REGULATION IS NOT REQUIRED FOR DIFFERENTIATION OF MULTIDRUG-RESISTANT HL-60 LEUKEMIA-CELLS, Leukemia research, 20(2), 1996, pp. 101-107
Authors:
BLAGOSKLONNY MV
TORETSKY J
BOHEN S
NECKERS L
Citation: Mv. Blagosklonny et al., MUTANT CONFORMATION OF P53 TRANSLATED IN-VITRO OR IN-VIVO REQUIRES FUNCTIONAL HSP90, Proceedings of the National Academy of Sciences of the United Statesof America, 93(16), 1996, pp. 8379-8383
Citation: Mv. Blagosklonny et Ws. Eldeiry, IN-VITRO EVALUATION OF A P53-EXPRESSING ADENOVIRUS AS AN ANTICANCER DRUG, International journal of cancer, 67(3), 1996, pp. 386-392
Authors:
BLAGOSKLONNY MV
SCHULTE T
NGUYEN P
TREPEL J
NECKERS LM
Citation: Mv. Blagosklonny et al., TAXOL-INDUCED APOPTOSIS AND PHOSPHORYLATION OF BCL-2 PROTEIN INVOLVESC-RAF-1 AND REPRESENTS A NOVEL C-RAF-1 SIGNAL-TRANSDUCTION PATHWAY, Cancer research, 56(8), 1996, pp. 1851-1854
Citation: Mv. Blagosklonny et al., PROTEASOME-DEPENDENT REGULATION OF P21(WAF1 CIP1) EXPRESSION/, Biochemical and biophysical research communications, 227(2), 1996, pp. 564-569
Citation: Mv. Blagosklonny et Lm. Neckers, THE ROLE OF BCL-2 PROTEIN AND AUTOCRINE GROWTH-FACTORS IN A HUMAN FOLLICULAR LYMPHOMA-DERIVED B-CELL LINE, European cytokine network, 6(1), 1995, pp. 21-27